217 related articles for article (PubMed ID: 17207604)
1. Maple syrup urine disease: diffusion MRI, and proton MR spectroscopy findings.
Sener RN
Comput Med Imaging Graph; 2007 Mar; 31(2):106-10. PubMed ID: 17207604
[TBL] [Abstract][Full Text] [Related]
2. Maple syrup urine disease: metabolic decompensation monitored by proton magnetic resonance imaging and spectroscopy.
Felber SR; Sperl W; Chemelli A; Murr C; Wendel U
Ann Neurol; 1993 Apr; 33(4):396-401. PubMed ID: 8489211
[TBL] [Abstract][Full Text] [Related]
3. MR diffusion imaging and MR spectroscopy of maple syrup urine disease during acute metabolic decompensation.
Jan W; Zimmerman RA; Wang ZJ; Berry GT; Kaplan PB; Kaye EM
Neuroradiology; 2003 Jun; 45(6):393-9. PubMed ID: 12736767
[TBL] [Abstract][Full Text] [Related]
4. Water apparent diffusion coefficient and T2 changes in the acute stage of maple syrup urine disease: evidence of intramyelinic and vasogenic-interstitial edema.
Righini A; Ramenghi LA; Parini R; Triulzi F; Mosca F
J Neuroimaging; 2003 Apr; 13(2):162-5. PubMed ID: 12722501
[TBL] [Abstract][Full Text] [Related]
5. Teaching NeuroImages: MRI in maple syrup urine disease.
Bindu PS; Kovoor JM; Christopher R
Neurology; 2010 Jan; 74(3):e12. PubMed ID: 20083792
[No Abstract] [Full Text] [Related]
6. [Acute encephalopathy due to late-onset maple syrup urine disease in a school boy].
Qu SQ; Yang LC; Luan Z; Du K; Yang H
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Mar; 14(3):161-4. PubMed ID: 22433398
[TBL] [Abstract][Full Text] [Related]
7. [3 patients with maple syrup urine disease].
Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E
An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657
[TBL] [Abstract][Full Text] [Related]
8. [Intermittent maple syrup urine disease in a 12-year-old boy: clinical aspects, diagnosis and treatment].
Fritsch G; Langenbeck U; Wendel U; Lehnert W; Palm W; Steger W
Klin Padiatr; 1983; 195(5):351-4. PubMed ID: 6632715
[TBL] [Abstract][Full Text] [Related]
9. Maple syrup urine disease in Thai infants.
Pangkanon S; Charoensiriwatana W; Sangtawesin V
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S41-4. PubMed ID: 19255991
[TBL] [Abstract][Full Text] [Related]
10. Neonatal case of classic maple syrup urine disease: usefulness of (1) H-MRS in early diagnosis.
Sato T; Muroya K; Hanakawa J; Asakura Y; Aida N; Tomiyasu M; Tajima G; Hasegawa T; Adachi M
Pediatr Int; 2014 Feb; 56(1):112-5. PubMed ID: 24548198
[TBL] [Abstract][Full Text] [Related]
11. Intermediate maple syrup urine disease: neuroimaging observations in 3 patients from South India.
Bindu PS; Shehanaz KE; Christopher R; Pal PK; Ravishankar S
J Child Neurol; 2007 Jul; 22(7):911-3. PubMed ID: 17715290
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted MRI of maple syrup urine disease encephalopathy.
Cavalleri F; Berardi A; Burlina AB; Ferrari F; Mavilla L
Neuroradiology; 2002 Jun; 44(6):499-502. PubMed ID: 12070724
[TBL] [Abstract][Full Text] [Related]
13. Restoration of brain stem auditory-evoked potential in maple syrup urine disease.
Spankovich C; Lustig LR
Otol Neurotol; 2007 Jun; 28(4):566-9. PubMed ID: 17414178
[TBL] [Abstract][Full Text] [Related]
14. Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis.
Kilicarslan R; Alkan A; Demirkol D; Toprak H; Sharifov R
Jpn J Radiol; 2012 Jul; 30(6):522-5. PubMed ID: 22476847
[TBL] [Abstract][Full Text] [Related]
15. Plasma amino acid analyses in two cases of maple syrup urine disease.
Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
[TBL] [Abstract][Full Text] [Related]
16. Branched-chain alpha-keto acids for the diagnosis of maple-syrup-urine disease.
Parsons H; Fung E; Snyder FF
N Engl J Med; 1987 Apr; 316(15):951. PubMed ID: 3821846
[No Abstract] [Full Text] [Related]
17. Diagnostic tools of early brain disturbances in an asymptomatic neonate with maple syrup urine disease.
Terek D; Koroglu O; Yalaz M; Gokben S; Calli C; Coker M; Kultursay N
Neuropediatrics; 2013 Aug; 44(4):208-12. PubMed ID: 23341096
[TBL] [Abstract][Full Text] [Related]
18. Maple syrup urine disease: diffusion-weighted and diffusion-tensor magnetic resonance imaging findings.
Parmar H; Sitoh YY; Ho L
J Comput Assist Tomogr; 2004; 28(1):93-7. PubMed ID: 14716239
[TBL] [Abstract][Full Text] [Related]
19. [Maple syrup urine disease].
Indo Y; Matsuda I
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):201-4. PubMed ID: 9590028
[No Abstract] [Full Text] [Related]
20. [The intermediate form of maple syrup disease].
Rittinger O; Bachmann C; Irnberger T; Pilz P; Walter GF; Wendel U; Plöchl E
Klin Padiatr; 1986; 198(1):37-43. PubMed ID: 3959487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
